Real-World Data
Unlock powerful insights with one of the world's largest healthcare data repositories – featuring 1.5 billion data points.
Premier Healthcare Database: An Unparalleled Resource
Not all databases are built to deliver the same value. The Premier Healthcare Database (PHD) integrates clinical and quality datasets for deep insights. One of the most comprehensive electronic healthcare data repositories, it incorporates data from more than 1,400 hospitals and healthcare systems.
Comprehensive Data
A HIPAA-compliant, retrospective database, the PHD comprises U.S. hospital-based, service-level, all-payer information on inpatient discharges (representing about 25 percent of annual U.S. inpatient admissions) and more than 1.3 billion outpatient visits.*
Unlike most healthcare databases, the PHD also includes chargemaster data. When paired with claims data, this data set – the largest of its kind in the country – identifies every device and drug used, delivering essential context to inform the decision-making process.
Need to make connections between disparate datasets? Using tokenization, we can easily link them. The PHD is tokenized in every major tokenization engine. This expedites data pulls and analyses – and helps supply solutions for even the steepest challenges.
AI-Driven Data Processing
The PHD’s robust, de-identified patient datasets are combined with AI-powered machine learning (ML) that processes the data and recognizes patterns – with natural language processing (NLP) that can read and interpret more than 2 million records per hour, placing even the most needle-in-a-haystack insights at your fingertips.
The PHD integrates new data in real time, ensuring you have access to the most current information for critical decision-making.
The Premier Healthcare Database Includes:
Supports improved clinical decision-making and patient care, especially in multimorbidity cases where two or more chronic diseases are present.
Provides information on interventions used as well as cost of care, physicians, drugs, diagnoses, department detail and demographics.
Includes access to structured clinical data, such as vitals and lab results, and unstructured abstract data types.
Includes access to structured clinical data, such as vitals and lab results, and unstructured aEncompasses those covered by Medicaid and Medicare Advantage as well as the commercially insured – illuminating enrollment history, healthcare claims and both medical and pharmacy claims from all care settings. Compared to open claims, closed claims deliver a more longitudinal view outside of the inpatient healthcare system.bstract data types.
Shows SKU-level direct and distributor orders from provider enterprise reporting (ERP) systems, which returns near real-time market share insights.
Offer a wealth of data to round out the PHD.
Far-Reaching Benefits
Advancements in RWD have forged an unprecedented opportunity to use RWE across nearly every segment of the healthcare ecosystem. Here are just a handful of ways life sciences and medical device companies can leverage the PHD:
Improved Supply Chain Management
The PHD delivers rich insights about healthcare provider needs, optimizing inventory management and streamlining the supply chain based on real-time data insights.
Product Development and Market Insights
Life sciences and medical device companies can use PHD data to inform product development and market segmentation and develop targeted marketing strategies.
Regulatory Compliance and Reporting
Stay compliant with industry regulations by providing accurate and timely data for standard reporting and regulatory audits.
Data in Action: Achieving Research Savings of Up to $3 Million
One medical device company partnered with Premier Applied Sciences to streamline their processes, save money and avoid more randomized clinical trials (RCTs). The company wanted to analyze their device and its safety, outcomes and benefits to patients from utilization. Understanding these factors would allow the company to expand indications to align with outcomes and generate RWE to enhance its device utilization.
By leveraging the PHD and working with the Premier team to draw powerful insights, the medical device company was able to reduce their launch research spend by up to $3 million.
The Premier Difference
The gold-standard PHD fuels evidence-based and population-based analyses of drugs, devices, other treatments, disease states, epidemiology, resource utilization, healthcare economics and clinical outcomes, as well as market and operational analyses. Add an expert partner with deep experience and a vast network that includes two-thirds of all healthcare providers in the U.S., and you get a robust framework for using RWD and RWE to achieve significant advancements in the field. Our staff of clinicians and data scientists leverages more than 100 years of combined research to deliver novel, actionable insights that move the needle. What’s more, the PHD integrates seamlessly with existing systems and workflows, making it easy for you to use the database without disruption.
Learn More About the Premier Healthcare Database
*As of July 2024. Information in the PHD, a retrospective database, is de-identified and HIPAA-compliant in accordance with the HIPAA Privacy Rule.